San Diego startup Erasca said Tuesday it has raised $64 million to develop cancer therapies with the ambitious goal of eventually curing the disease.
The new funding is up from the $42 million reported in December.
New investors in privately held Erasca include ARCH Venture Partners; Andreessen…
